PA007513.m2a: In Vivo Grade Recombinant Anti-mouse VEGF Monoclonal Antibody (Clone: B20-4.1.1.1), Mouse IgG2a Kappa
The in vivo grade recombinant anti-mouse VEGF mouse IgG2a kappa monoclonal antibody was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: B20-4.1.1.1) specifically binds to mouse VEGF.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the mouse VEGF protein.BP000929-ENZ-460: Recombinant Human Guanidinoacetate N-Methyltransferase
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP002388-Z53: Recombinant Human Cellular tumor antigen p53 (p53) Protein
Source: Baculovirus, SF9 insect cells-derived.
Bioactivity test: 1 unit equals 1 nanogram of purified protein. 10 unit is sufficient for a gel mobility shift assay in a 20 ul reaction; 50 units are sufficient for reconstituted transcription assay and 100 units are sufficient for a protein-protein interaction assay.
Purity: > 95%, by SDS-PAGE.
Endotoxin Level: < 1.0 EU per 1 ug of the protein by the LAL method.BP001892-PRO-051: Recombinant Human Chromosome 12 Open Reading Frame 5 (C12ORF5) Protein
Source: E. coli-derived.
Purity: > 90.0% as determined by SDS-PAGE.BP002388-PRO-301: Recombinant Human p53 Mutant (a.a 135) (p53M) Protein
Source: E. coli-derived.
Applications: ELISA; Inhibition Assays; Western Blotting.BP000381-C180: Recombinant Human Thymopoietin (TP) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP002388-PRO-742: Recombinant Human Cellular tumor antigen p53 (p53) Protein
Source: E. coli-derived.BP002211-PRO-1185: Recombinant Human TP53RK binding protein (TPRKB)
Source: E. coli-derived.
Purity: > 95% as determined by SDS-PAGE.BP005086: Cynomolgus/Rhesus macaque CD27/TNFRSF7 Protein with the C-hFc Tag
Source: The recombinant Cynomolgus/Rhesus macaque CD27/TNFRSF7 Protein, (amino acids Ala20-Arg191) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Cynomolgus CD27 Ligand protein with the C-hFc tag at 2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Cynomolgus/Rhesus macaque CD27 protein with the C-hFc tag with the EC50 of 41.3 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005326: Human CD27/TNFRSF7 Protein with the C-His Tag
Source: The recombinant Human CD27/TNFRSF7 Protein, (amino acids Thr21-Ile192) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human CD27 protein with the C-His tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Human CD27 Ligand protein with the C-hFc tag with the EC50 of 14.2 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005787: Human CD27/TNFRSF7 Protein with the C-hFc Tag
Source: The recombinant Human CD27/TNFRSF7 Protein, (amino acids Thr21-Ile192) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human CD27 Ligand Trimer protein with the C-hFc tag at 2 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human CD27 protein with the C-hFc tag with the EC50 of 13.5 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.